BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14301047)

  • 1. [INTRAOPERATIVE USE OF MITOMYCIN C WITH SPLEEN AND BONE MARROW SHIELDING TECHNIQUE IN GASTRIC CANCER SURGERY].
    INOKUCHI K; NAKAMURA T; IENAGA S; AKIYOSHI T; IKEDA T
    Gan No Rinsho; 1965 Mar; 11():142-50. PubMed ID: 14301047
    [No Abstract]   [Full Text] [Related]  

  • 2. [EVALUATION OF ADJUVANT POSTOPERATIVE CHEMOTHERAPY AND RADIATION THERAPY IN GASTRIC CANCER].
    KIKUCHI K; ANEHA Y; YAMANAKA M; TANEICHI T; NATSUME R; KANNO H; NAGANUMA H; SATO Y; YOSHIZUMI M; KUNII Y; SATO T; YAMAGATA S; WATANABE R
    Gan No Rinsho; 1964 Nov; 10():800-5. PubMed ID: 14253637
    [No Abstract]   [Full Text] [Related]  

  • 3. Spleen and bone marrow shielding technique in intraoperative adjuvant chemotherapy for gastric cancer.
    Inokuchi K; Nakamura T; Ienaga S; Akiyoshi T; Ikeda T
    J Antibiot (Tokyo); 1966 Mar; 19(2):78-84. PubMed ID: 5952896
    [No Abstract]   [Full Text] [Related]  

  • 4. LARGE-DOSE ADMINISTRATION OF MITOMYCIN-C DURING GASTRECTOMY FOLLOWED BY HOMOLOGOUS BONE MARROW TRANSPLANTATION.
    HATTORI T; ITO I; HIRATA K
    Gan; 1964 Jun; 55():211-24. PubMed ID: 14188565
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF MITOMYCIN C UPON STOMACH CANCER (FROM FOLLOW-UP STUDY OF GASTRECTOMY).
    KATSUMI M; SHINO K; OKAMURA T; KARIYA Y; IWAHASHI H; NAKASE Y; NISHIGAKI A; SHIOZAKI A
    Wakayama Med Rep; 1964 Mar; 8():55-62. PubMed ID: 14295269
    [No Abstract]   [Full Text] [Related]  

  • 6. [MASSIVE DOSES OF MITOMYCIN DURING SURGERY--THEORY AND RESULTS DURING PALLIATIVE EXCISION IN STOMACH CANCER].
    HATTORI T; ITO H; MIWA K; HIRATA K; FUJITA H; ENDO S
    Gan No Rinsho; 1964 Feb; 10():96-105. PubMed ID: 14150030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies on the effects of shielding the spleen and bone marrow in massive dosage of mitomycin C].
    Ikejiri K
    Igaku Kenkyu; 1967 Oct; 37(5):471-89. PubMed ID: 5627805
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON CONTINUOUS INTRA-HYPOGASTRIC ARTERIAL INFUSION OF ANTICARCINOGENIC AGENTS IN PATIENTS WITH CERVICAL CANCER AS A SUPPLEMENTARY THERAPY TO SURGICAL OPERATION].
    IZUCHI S
    Gan No Rinsho; 1964 Sep; 10():689-96. PubMed ID: 14209132
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; Macdonald JS; Hoth D; Wooley PV
    Cancer Chemother Pharmacol; 1978; 1(2):73-5. PubMed ID: 750107
    [No Abstract]   [Full Text] [Related]  

  • 10. [CHEMOTHERAPY IN TREATMENT OF CARCINOMA OF THE OVARY].
    OGIER E; MAIJNELLI M; PERITI P
    Riv Ostet Ginecol; 1964 Oct; 19():610-29. PubMed ID: 14237193
    [No Abstract]   [Full Text] [Related]  

  • 11. [SOME PROBLEM OF SURGICAL OPERATION ACCOMPANIED WITH ANTICANCER AGENTS AND RADIATION THERAPY FOR MALIGNANT TUMORS, ESPECIALLY OF THEIR SIDE-EFFECTS].
    WATANABE T
    Showa Igakkai Zasshi; 1964 Apr; 24():39-55. PubMed ID: 14205048
    [No Abstract]   [Full Text] [Related]  

  • 12. CHEMOTHERAPY OF GASTRIC CANCER.
    OHARA T
    Acta Unio Int Contra Cancrum; 1964; 20():63. PubMed ID: 14151985
    [No Abstract]   [Full Text] [Related]  

  • 13. [The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice].
    Sawada H; Nakatani K; Miyagi N; Ezaki T; Sugisaki T; Watanabe A; Nishiwada T; Okumura T; Shiratori T; Konishi Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1807-9. PubMed ID: 2453164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
    Iwamoto A; Takahashi T; Sasabe T; Itoh M; Kondoh S; Seiki K; Yoneyama C; Shimotsuma M; Hagiwara A; Yamaguchi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2748-51. PubMed ID: 2506820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EXPERIMENTAL STUDIES ON THE PREVENTION OF HEMATOGENIC METASTASIS OF CANCER WITH ANTICANCER DRUGS].
    UENO K
    Kumamoto Igakkai Zasshi; 1964 Feb; 38():81-99. PubMed ID: 14162556
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and-or allogeneic bone marrow transplantation.
    Hattori T; Mori A; Hirata K; Ito I
    Gan; 1972 Oct; 63(5):517-22. PubMed ID: 4566613
    [No Abstract]   [Full Text] [Related]  

  • 17. PRESENT-DAY MANAGEMENT OF GASTRIC CANCER.
    MARSHALL SF
    Postgrad Med; 1964 Apr; 35():374-7. PubMed ID: 14131635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dosage and its safety in intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer].
    Hiratsuka M; Ogawa A; Ohigashi H; Kameyama M; Sasaki Y; Ishikawa O; Kabuto T; Fukuda I; Furukawa H; Imaoka S
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1574-9. PubMed ID: 3141534
    [No Abstract]   [Full Text] [Related]  

  • 19. BEGINNING CANCER OF THE STOMACH IN JAPAN.
    AZUMA Y
    Pac Med Surg; 1964; 72():324-6. PubMed ID: 14218718
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitomycin therapy in gastric cancer.
    Schnall S; Macdonald JS
    Oncology; 1993 Apr; 50 Suppl 1():70-7. PubMed ID: 8483560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.